SS
Therapeutic Areas
Omniscient Neurotechnology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Quicktome Clinical Suite | Neurosurgical planning (tumor resection, stroke, epilepsy) | Commercial |
| Quicktome Research Suite | Neuroscience research (connectomics, biomarker discovery) | Commercial |
Leadership Team at Omniscient Neurotechnology
DM
Dr. Michael Sughrue
Co‑Founder, Chief Medical Officer
DS
Dr. Stephane Doyen
Co‑Founder, Chief Data Scientist